Ignite Creation Date:
2024-05-06 @ 7:03 PM
Last Modification Date:
2024-10-26 @ 2:59 PM
Study NCT ID:
NCT05875623
Status:
RECRUITING
Last Update Posted:
2023-10-19
First Post:
2023-05-16
Brief Title:
Impact of Medications Review on Potentially Inappropriate Medications and Clinical Outcomes Among Hospitalized Older Adults
Sponsor:
Monash University
Organization:
Monash University
Study Overview
Official Title:
Impact of Medications Review on Potentially Inappropriate Medications and Clinical Outcomes Among Hospitalized Older Adults A Randomized Controlled Trial REVMED RCT Protocol
Status:
RECRUITING
Status Verified Date:
2023-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The goal of this randomized controlled trial is to assess the effectiveness of a pharmacist-led medication review using the locally developed Malaysian Potentially Inappropriate Prescribing Screening tool in Older Adults MALPIP an explicit criteria in hospitalized older adults The main questions it aims to answer are
1 The effectiveness of the intervention in reducing the number of PIMs and chronic medications after discharge
2 The impact of the intervention on quality of life falls events emergency department visits readmissions and survivals
Researchers will compare the control group to see if there is corresponding changes to the outcomes specified above
1 The effectiveness of the intervention in reducing the number of PIMs and chronic medications after discharge
2 The impact of the intervention on quality of life falls events emergency department visits readmissions and survivals
Researchers will compare the control group to see if there is corresponding changes to the outcomes specified above
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None